1435TiP Adjuvant immunotherapy for resected esophageal squamous cell carcinoma with high risk of recurrence (AIRES): A multicenter, open-label, randomized, controlled phase III trial
2021 ◽
Vol 32
◽
pp. S1072-S1073
X. Kang
◽
J. Xu
◽
R. Zhang
◽
Y. Song
◽
Z. Wang
◽
...
2014 ◽
Vol 25
◽
pp. iv211
◽
S. Wu
◽
X. Zhang
◽
B. Xia
◽
H. Luo
◽
J. Li
◽
...
2021 ◽
Vol 32
◽
pp. S1454-S1455
H. Jiang
◽
X. Shang
◽
C. Zhang
◽
J. Yue
◽
X. Duan
◽
...
2004 ◽
Vol 15
(6)
◽
pp. 947-954
◽
J.-L. Lee
◽
S.I. Park
◽
S.-B. Kim
◽
H.-Y. Jung
◽
G.H. Lee
◽
...
Wenjie Ni
◽
Shufei Yu
◽
Zefen Xiao
◽
Zongmei Zhou
◽
Dongfu Chen
◽
...
Wei Deng
◽
Jinsong Yang
◽
Wenjie Ni
◽
Chen Li
◽
Xiao Chang
◽
...
2019 ◽
Vol 39
(9)
◽
pp. 5123-5133
◽
SOOK RYUN PARK
◽
DOK HYUN YOON
◽
JONG HOON KIM
◽
YONG-HEE KIM
◽
HYEONG RYUL KIM
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. TPS197-TPS197
◽
C. Liberatoscioli
◽
J. A. Langendijk
◽
C. Van Herpen
◽
L. Collette
◽
E. M. Ozsahin
◽
...
2016 ◽
Vol 27
◽
pp. vi563
◽
J. Huang
◽
Y. Liu
◽
S. Dai
◽
P. Lu
◽
Y. Ba
◽
...
2018 ◽
Vol 13
(11)
◽
pp. 1743-1749
◽
Shun Lu
◽
Zhiwei Chen
◽
Chengping Hu
◽
Jian Zhang
◽
Yuan Chen
◽
...
Jing Huang
◽
Binghe Xu
◽
Ying Liu
◽
Junxing Huang
◽
Ping Lu
◽
...
Close
Export Citation Format
Close
Share Document
Close